Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Research Cooperative Agreement To Promote the Health of People With Intellectual Disabilities, Request for Application (RFA) DD07-012, 17168-17169 [E7-6444]
Download as PDF
<![CDATA[
17168
Federal Register / Vol. 72, No. 66 / Friday, April 6, 2007 / Notices
(1) Extent to which applicant
demonstrates that the project costs and
budget information submitted for the
proposed program are reasonable and
justified in terms of the proposed tasks
and the anticipated results and benefits;
and,
(2) Extent to which the fiscal control
and accounting procedures are adequate
to ensure prudent use, proper and
timely disbursement, and an accurate
accounting of funds received under this
announcement.
Review and Selection Process
Each application submitted to the
OPHS Office of Grants Management will
be screened to determine whether it was
received by the closing date and time.
The results of a competitive review
are a primary factor in making funding
decisions. In addition, Federal staff will
conduct administrative reviews of the
applications and, in light of the results
of the competitive review, will
recommend applications for funding to
the Deputy Assistant Secretary for
Population Affairs (DASPA). The
DASPA may also solicit and consider
comments from others within DHHS in
making funding decisions. Final grant
awards decisions will be made by the
DASPA. The DASPA will fund those
projects which will, in his/her
judgment, best promote the purposes of
this program, within the limits of funds
available for such projects.
VI. Award Administration Information
1. Award Notices
pwalker on PROD1PC71 with NOTICES
The OPA does not release information
about individual applications during the
review process. When final decisions
have been made, successful applicants
will be notified by letter of the outcome
of the final funding decisions. The
official document notifying an applicant
that a project as been approved for
funding is the Notice of Grant Award
(NGA), signed by the OPHS Grants
Management Officer, which sets forth
the amount of funds granted, the terms
and conditions of the award, the
effective date of the grant, the budget
period for which initial support will be
given, and the total project period for
which support is contemplated. Every
effort will be made to notify all
unsuccessful applicants as soon as
possible after final decisions are made.
2. Administrative and National Policy
Requirements
In accepting this award, the grantee
stipulates that the award and any
activities thereunder are subject to all
provisions in 45 CFR parts 74 (nongovernmental) and 92 (governmental)
VerDate Aug<31>2005
18:39 Apr 05, 2007
Jkt 211001
currently in effect or implemented
during the period of the grant.
The DHHS Appropriations Act
requires that when issuing statements,
press releases, requests for proposals,
bid solicitations, and other documents
describing projects or programs funded
in whole or in part with Federal money,
grantees shall clearly state the
percentage and dollar amount of the
total costs of the program or project
which will be financed with Federal
money and the percentage and dollar
amount of the total costs of the project
or program that will be financed by nongovernmental sources.
3. Reporting Requirements
A successful applicant under this
notice will submit: (a) Progress reports;
(b) annual Financial Status Reports; and
(c) a final performance report, including
an evaluation report, and Financial
Status Report. Reporting formats are
established in accordance with
provisions of the general regulations
which apply under 45 CFR parts 74 and
92. Applicants must submit all required
reports in a timely manner, in
recommended formats, and submit a
final report on the project, including
any information on evaluation results, at
the completion of the project period.
The final performance report should
contain an overview of the program
from start to finish, including
information on: (a) Summary of the
project, (b) state of the major goals and
objectives of the project, (c) list of
significant accomplishments, (d)
description of innovative features, (e)
statement of significant problems
encountered and solutions developed,
(f) a complete written disclosure of any
invention, curriculum, publication,
video, pamphlet conceived or produced
as part of the grant funded project, (g)
a copy of any products developed in
association with the project. The final
evaluation report should reflect an
assessment of the program. It should
describe factors contributing to both
program success and problem areas. The
report should include a description of
the project’s objectives, interventions,
evaluation model and hypotheses,
findings, and conclusions. The report
should include a summary of the
program statistics and findings. It
should discuss the implications of
project findings as they relate to the
project objectives, as well as a set of
recommendations based on the findings
(where appropriate). The appendices to
the evaluation report should include
any data collection instruments and
relevant references. Copies of any
published articles, based on the project
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
or project evaluation findings are also
requested.
Agencies receiving $500,000 or more
in total Federal funds are required to
undergo an annual audit as described in
OMB Circular A–133, ‘‘Audits of States,
Local Governments, and Non-Profit
Organizations.’’
VII. Agency Contacts
For application kits, submission of
applications, and information on budget
and business aspects of the application,
please contact: WilDon Solutions, Office
of Grants Management Operations
Center, 1515 Wilson Blvd., Third Floor
Suite 310, Arlington, VA 22209 at
1–888–203–6161, e-mail
OPHSgrantinfo@teamwildon.com, or fax
703–351–1138.
Program Office Contact: Evelyn
Kappeler, Department of Health and
Human Services, Office of Public Health
and Science, Office of Population
Affairs, 1101 Wootton Parkway, Suite
700, Rockville, Maryland 20852. E-mail:
Evelyn.Kappeler@hhs.gov; telephone:
240–453–2837.
Dated: April 2, 2007.
Evelyn M. Kappeler,
Acting Director, Office of Population Affairs.
[FR Doc. E7–6433 Filed 4–5–07; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Research
Cooperative Agreement To Promote
the Health of People With Intellectual
Disabilities, Request for Application
(RFA) DD07–012
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned SEP:
Time and Date: 12 p.m.–4 p.m., May 31,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to RFA DD07–012, ‘‘Research
Cooperative Agreement to Promote the
E:\FR\FM\06APN1.SGM
06APN1
Federal Register / Vol. 72, No. 66 / Friday, April 6, 2007 / Notices
Health of People with Intellectual
Disabilities.’’
Contact Person for More Information:
Juliana Cyril, Ph.D., Associate Director for
Policy and Peer Review, Centers for Disease
Control and Prevention, 1600 Clifton Road
NE, Mailstop D72, Atlanta, GA 30333,
Telephone 404.639.4639.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6444 Filed 4–5–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10003, CMS–
901A and D, CMS–9044, CMS–R–193 and
CMS–10066]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Notice of Denial
of Medical Coverage (NDMC), and the
Notice of Denial of Payment (NDP) and
pwalker on PROD1PC71 with NOTICES
AGENCY:
VerDate Aug<31>2005
18:39 Apr 05, 2007
Jkt 211001
supporting regulations in 42 CFR
422.568; Use: Section 1852(g)(1)(B) of
the Statute requires Medicare Health
organizations (Medicare Advantage,
cost, and Health Care Prepayment Plans)
to provide determinations to deny
coverage (i.e., medical services or
payment) in writing and include a
statement in understandable language of
the reasons for the denial and a
description of the reconsideration and
appeals processes. These notices fulfill
the regulatory requirement. Form
Number: CMS–10003 (OMB#: 0938–
0829); Frequency: Reporting: Yearly;
Affected Public: Business or other forprofit and not-for-profit institutions;
Number of Respondents: 454; Total
Annual Responses: 105,138; Total
Annual Hours: 26285.
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: CMS
Application for Federal Qualification
(901A); CMS Medicare Agreement
Application (901D) and Supporting
Regulations in 42 CFR Section 417.143
and 422.6; Use: Prepaid health plans
must meet certain regulatory
requirements to be federally qualified
health maintenance organizations or to
enter into a contract with CMS to
provide health benefits to Medicare
beneficiaries. The application forms are
used by CMS to collect information
about a health plan to determine their
compliance with Federal regulations.
Form Number: CMS–901A and D
(OMB#: 0938–0470); Frequency:
Reporting: Once; Affected Public:
Business or other for-profit and not-forprofit institutions; Number of
Respondents: 55; Total Annual
Responses: 55; Total Annual Hours:
2,200.
3. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare ESRD
Exceptions; Use: This information is
collected in accordance with section
2145 of the Omnibus Budget
Reconciliation Act of 1981 and section
623 of the Medicare Prescription Drug
Improvement and Modernization Act of
2003. End Stage Renal Disease (ESRD)
facilities can file for an exception to its
composite payment rate. CMS uses the
information submitted to determine
whether an ESRD facility qualifies for a
rate increase and the amount of the
increase. Form Number: CMS–9044
(OMB#: 0938–0296); Frequency:
Reporting: Occasionally; Affected
Public: Business or other for-profit and
not-for-profit institutions; Number of
Respondents: 10; Total Annual
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
17169
Responses: 10; Total Annual Hours:
400.
4. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare and
Medicare Advantage Programs;
Notification Procedures for Hospital
Discharges—Important Message from
Medicare Use: Requirements that
hospitals notify beneficiaries in
inpatient hospital settings of their rights
as a hospital patient including their
discharge appeal rights are referenced in
Section 1866(a)(1)(M) of the Social
Security Act (The Act). The authority
for the right to an expedited
determination is set forth at Section
1869(c)(3)(C)(iii)(III) of the Act. Under
sections 42 CFR 405.1205 and 422.620,
the hospital must deliver valid, written
notice, the Important Message from
Medicare (IM), of a patient’s rights as a
hospital patient including the discharge
appeal rights, within 2 calendar days of
admission. A follow-up copy of the
signed IM is given again as far as
possible in advance of discharge, but no
more than 2 calendar days before.
Follow-up notice is not required if the
provision of the admission IM, falls
within 2 calendar days of discharge.
Several changes are being proposed to
the IM, including but not limited to the
following: 1. Patient Information
section: CMS removed the ‘‘Date of
Notice’’ line. 2. Your Rights as Hospital
Inpatient section: (a) There are several
proposed clarifying language updates.
(b) CMS added a bullet stating that the
beneficiary can call the Quality
Improvement Organization (QIO) for
quality of care concerns based on
information currently contained in the
Medicare and You 2007 booklet. 3. Your
Hospital Discharge and Medicare
Appeal Rights section: CMS added a
bullet stating that the beneficiary may
call 1–800 Medicare and added
supporting rational for when to call. 4.
CMS added instructions for the
beneficiary or representative to both
sign and date the notice and, 5. CMS
added an ‘‘Additional Information’’
space requesting that hospitals be able
to add signature lines for hospital staff
documentation. Form Number: CMS–R–
193 (OMB#: 0938–0692); Frequency:
Reporting: Yearly; Affected Public:
Business or other for-profit and not-forprofit institutions; Number of
Respondents: 6000; Total Annual
Responses: 13,000,000; Total Annual
Hours: 3,250,000.
5. Type of Information Collection
Request: New Collection; Title of
Information Collection: Medicare and
Medicare Advantage Programs;
Notification Procedures for Hospital
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 72, Number 66 (Friday, April 6, 2007)]
[Notices]
[Pages 17168-17169]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6444]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Research Cooperative Agreement To Promote the
Health of People With Intellectual Disabilities, Request for
Application (RFA) DD07-012
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
SEP:
Time and Date: 12 p.m.-4 p.m., May 31, 2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
RFA DD07-012, ``Research Cooperative Agreement to Promote the
[[Page 17169]]
Health of People with Intellectual Disabilities.''
Contact Person for More Information: Juliana Cyril, Ph.D.,
Associate Director for Policy and Peer Review, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop D72, Atlanta,
GA 30333, Telephone 404.639.4639.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-6444 Filed 4-5-07; 8:45 am]
BILLING CODE 4163-18-P
